Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need ...

Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company Institutions' substantial holdings in Abbott Laboratories implies that they have ...

Highlight,-Analysts give Abbott Laboratories a "Moderate Buy" rating with a target price of $130.07.,-Recent dividend ...

On Thursday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.26 which represents a slight increase of $1.33 or 1.15% from the prior close of $115.93. The stock opened at ...

We recently compiled a list of the 8 Magnificent Dividend Growth Stocks to Buy Now. In this article, we are going to take a ...

Over half a decade, Abbott Laboratories managed to grow its earnings per share at 12% a year. The EPS growth is more ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Unfortunately for shareholders, while the Abbott Laboratories (NYSE:ABT) share price is up 38% in the last five years, that's less than the market return. Zooming in, the stock is up a respectable ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) on November 15 and set a price ...

On Thursday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $115.03 which represents a decrease of $-0.71 or -0.61% from the prior close of $115.74. The stock opened at $115.98 and ...